Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor medication that is used in the treatment of breast cancer for post-menopausal women.
Applications & Research
Explore the main themes, entities and connections around Letrozole. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
aromatase breast women also used cancer use inhibitor tamoxifen post-menopausal shown treatment medication side effects medical drug antiestrogen estrogen effective
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Letrozole | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Letrozole | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Letrozole | ATC code | L02BG04 (WHO) | 1.00 | infobox |
| Letrozole | Bioavailability | 99.9% | 1.00 | infobox |
| Letrozole | CAS Number | 112809-51-5 Y | 1.00 | infobox |
| Letrozole | ChEBI | CHEBI:6413 Y | 1.00 | infobox |
| Letrozole | ChEMBL | ChEMBL1444 Y | 1.00 | infobox |
| Letrozole | ChemSpider | 3765 Y | 1.00 | infobox |
| Letrozole | CompTox Dashboard (EPA) | DTXSID4023202 | 1.00 | infobox |
| Letrozole | Drug class | Aromatase inhibitor; Antiestrogen | 1.00 | infobox |
| Letrozole | DrugBank | DB01006 Y | 1.00 | infobox |
| Letrozole | ECHA InfoCard | 100.200.357 | 1.00 | infobox |
| Letrozole | Elimination half-life | 2 days | 1.00 | infobox |
| Letrozole | Excretion | Kidney | 1.00 | infobox |
| Letrozole | Formula | C17H11N5 | 1.00 | infobox |
| Letrozole | IUPHAR/BPS | 5209 | 1.00 | infobox |
| Letrozole | KEGG | D00964 Y | 1.00 | infobox |
| Letrozole | Legal status | CA: Schedule VII | 1.00 | infobox |
| Letrozole | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Letrozole | Legal status | US: ℞-only | 1.00 | infobox |
| Letrozole | Legal status | EU: Rx-only | 1.00 | infobox |
| Letrozole | License data | US DailyMed: Letrozole | 1.00 | infobox |
| Letrozole | MedlinePlus | a698004 | 1.00 | infobox |
| Letrozole | Metabolism | pharmacologically-inactive metabolites Bis(4-cyanophenyl)methanol and 4,4'-dicyanobenzophenone. | 1.00 | infobox |
| Letrozole | Molar mass | 285.310 g·mol−1 | 1.00 | infobox |
| Letrozole | Protein binding | 60%, mainly to albumin | 1.00 | infobox |
| Letrozole | PubChem CID | 3902 | 1.00 | infobox |
| Letrozole | Routes of administration | By mouth | 1.00 | infobox |
| Letrozole | Trade names | Femara, others | 1.00 | infobox |
| Letrozole | UNII | 7LKK855W8I | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.